3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Small Cell Lung Carcinoma
6
Ovarian Neoplasms
3
Lung Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Neoplasm Metastasis
2
Fallopian Tube Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Metastatic Bladder Urothelial Carcinoma
1
Leiomyosarcoma
1
HRD Cancer
1
Colorectal Neoplasms
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Brain Neoplasms
1
Advanced Solid Tumor
1
Interventions
Injections
26
toripalimab
17
pembrolizumab
17
tislelizumab
12
Gemcitabine
8
Cisplatin
7
spartalizumab
6
atezolizumab
6
Irinotecan
6
Carboplatin
6
Paclitaxel
5
Oxaliplatin
5
Nivolumab
5
Leucovorin
5
Fluorouracil
5
camrelizumab
4
Pemetrexed
4
Docetaxel
4
Cetuximab
4
Capecitabine
4
trastuzumab deruxtecan
3
sintilimab
3
olaparib
3
lenvatinib
3
cediranib
3
PM 01183
3
Drug Therapy
3
Cyclophosphamide
3
Bevacizumab
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Solid Tumor
×
berzosertib
×
Clear all
NCT02157792
2020-04-01
M6620 First in Human Study
EMD Serono
Phase 1
Completed
200 enrolled